A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 291-298

  Saag, Michael S ^{a,b,c,d,e,f,g,h,i}   Cloud, Gretchen A ^{a,b,c,d,e,f,g,h}   Graybill, J Richard ^{a,b,c,d,e,f,g,h}   Sobel, Jack D ^{a,b,c,d,e,f,g,h}   Tuazon, Carmelita U ^{a,b,c,d,e,f,g,h}   Johnson, Philip C ^{a,b,c,d,e,f,g,h}   Fessel, W Jeffrey ^{a,b,c,d,e,f,g,h}   Moskovitz, Bruce L ^{a,b,c,d,e,f,g,h}   Wiesinger, Barbara ^{a,b,c,d,e,f,g,h}   Cosmatos, Dennis ^{a,b,c,d,e,f,g,h}   Riser, Laura ^{a,b,c,d,e,f,g,h}   Thomas, Carolynn ^{a,b,c,d,e,f,g,h}   Hafner, Richard ^{a,b,c,d,e,f,g,h}   Dismukes, William E ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^f KAISER PERMANENTE MEDICAL CENTER   (United States)

^g JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; FUNGAL MENINGITIS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

EID: 0033047485     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515110     Document Type: Article

References (19)

1. 1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17:837-42.
2. 2. van der Horst CM, Saag MS, Cloud GA, et al. A controlled trial of treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
3. 3. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
4. 4. Coker RJ, Viviani M, Gazzard BG, et al. Treatment of cryptococcosis with liposomal amphotericin B (Ambisome) in 23 patients with AIDS. AIDS 1993;7:829-35.
5. 5. Sharkey PK, Graybill JR, Johnson ES, et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996;22:315-22.
6. 6. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994;19:741-5.
7. 7. Bozzette SA, Larsen RA, Chiu J, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:580-4.
8. 8. Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:793-8.
9. 9. Saag MS, Dismukes WE. Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 1988;32:1-8.
10. 10. Denning DW, Tucker RM, Hostetler JS, Gill S, Stevens DA. Oral itraconazole therapy of cryptococcal meningitis and cryptococcosis in patients with AIDS. In: Vanden Bossche H, ed. Mycoses in AIDS patients. New York: Plenum Press, 1990:305-24.
11. 11. Moskovitz BL, Wiesinger B, Cryptococcal Meningitis Research Group. Randomized, comparative study of itraconazole and fluconazole for treatment of AIDS-related cryptococcal meningitis [abstract no 34]. In: First National Conference on Human Retroviruses and Related Infections. Washington, DC: American Society for Microbiology, 1993.
12. 12. de Grans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
13. 13. Harris CH, Wallace J, Foulds G, Rinaldi M. Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection. Antimicrob Agents Chemother 1989;33:714-6.
14. 14. Van Rompaey F. HPLC method for the determination of itraconazole and hydroxy-itraconazole in plasma samples. Evaluation and application to the study of the bioavailability and bioequivalence of itraconazole in man. Preclinical research report R51211/55; revised June 1990.
15. 15. Makuch R, Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treatment Rep 1978;62(7).
16. 16. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press, 1967.
17. 17. Kaplan ELL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. 18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
19. 19. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.